Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS

Abstract Acute coronary syndrome (ACS) is a clinical condition caused by a disturbance in myocardial blood flow. ACS can be basically divided into two forms: ST elevation myocardial infarction (STEMI) due to complete occlusion of the coronary artery and non-ST elevation myocardial infarction (NSTEMI...

Full description

Bibliographic Details
Main Authors: Gulsah Gundogdu, Fatma Demirkaya Miloglu, Onur Senol, Yavuzer Koza, Fuat Gundogdu
Format: Article
Language:English
Published: SpringerOpen 2019-10-01
Series:Journal of Analytical Science and Technology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40543-019-0191-3
_version_ 1818228784222961664
author Gulsah Gundogdu
Fatma Demirkaya Miloglu
Onur Senol
Yavuzer Koza
Fuat Gundogdu
author_facet Gulsah Gundogdu
Fatma Demirkaya Miloglu
Onur Senol
Yavuzer Koza
Fuat Gundogdu
author_sort Gulsah Gundogdu
collection DOAJ
description Abstract Acute coronary syndrome (ACS) is a clinical condition caused by a disturbance in myocardial blood flow. ACS can be basically divided into two forms: ST elevation myocardial infarction (STEMI) due to complete occlusion of the coronary artery and non-ST elevation myocardial infarction (NSTEMI) due to partial occlusion of the coronary artery. In this study, we aimed to monitor the metabolite profile of STEMI and NSTEMI patients and compare the results via untargeted metabolomics approach. Serum samples were collected from STEMI and NSTEMI patients, and each group consists of 20 participants. Extraction was achieved by acetonitrile, and chromatographic separation was performed by LC/Q-TOF/MS/MS accompanied with dual AJS ESI positive ion mode. METLIN, MATLAB 2017a-PLS Toolbox7.2, and Human Metabolome Database were utilized for bioinformatics evaluation of obtained findings. In our results, 203 m/z ratio was detected and 163 m/z ratio passed the significance criteria (fold analysis > 1.5 and p < 0.05). Twenty-five metabolites including BCAAs, LysoPC species, lactic acid, succinate, malonic acid, maleic acid, butyric acid, carnitine, and betaine were identified. In conclusion, new biomarker candidates were identified to differentiate the diagnosis of STEMI and NSTEMI. Identified metabolites are indicative of alterations in oxidative stress, hypoxia, TCA cycle, and amino acid metabolism.
first_indexed 2024-12-12T10:08:12Z
format Article
id doaj.art-329570593dc84ea3ad28d273b6e03b9f
institution Directory Open Access Journal
issn 2093-3371
language English
last_indexed 2024-12-12T10:08:12Z
publishDate 2019-10-01
publisher SpringerOpen
record_format Article
series Journal of Analytical Science and Technology
spelling doaj.art-329570593dc84ea3ad28d273b6e03b9f2022-12-22T00:27:53ZengSpringerOpenJournal of Analytical Science and Technology2093-33712019-10-011011910.1186/s40543-019-0191-3Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MSGulsah Gundogdu0Fatma Demirkaya Miloglu1Onur Senol2Yavuzer Koza3Fuat Gundogdu4Department of Physiology, Faculty of Medicine, Pamukkale UniversityAnalytical Chemistry Department, Eczacılık Fakültesi, Atatürk UniversityAnalytical Chemistry Department, Eczacılık Fakültesi, Atatürk UniversityCardiology Department, Tıp Fakültesi, Atatürk UniversityCardiology Department, Tıp Fakültesi, Atatürk UniversityAbstract Acute coronary syndrome (ACS) is a clinical condition caused by a disturbance in myocardial blood flow. ACS can be basically divided into two forms: ST elevation myocardial infarction (STEMI) due to complete occlusion of the coronary artery and non-ST elevation myocardial infarction (NSTEMI) due to partial occlusion of the coronary artery. In this study, we aimed to monitor the metabolite profile of STEMI and NSTEMI patients and compare the results via untargeted metabolomics approach. Serum samples were collected from STEMI and NSTEMI patients, and each group consists of 20 participants. Extraction was achieved by acetonitrile, and chromatographic separation was performed by LC/Q-TOF/MS/MS accompanied with dual AJS ESI positive ion mode. METLIN, MATLAB 2017a-PLS Toolbox7.2, and Human Metabolome Database were utilized for bioinformatics evaluation of obtained findings. In our results, 203 m/z ratio was detected and 163 m/z ratio passed the significance criteria (fold analysis > 1.5 and p < 0.05). Twenty-five metabolites including BCAAs, LysoPC species, lactic acid, succinate, malonic acid, maleic acid, butyric acid, carnitine, and betaine were identified. In conclusion, new biomarker candidates were identified to differentiate the diagnosis of STEMI and NSTEMI. Identified metabolites are indicative of alterations in oxidative stress, hypoxia, TCA cycle, and amino acid metabolism.http://link.springer.com/article/10.1186/s40543-019-0191-3STEMINSTEMIMetabolomicsLC/Q-TOF/MS/MS
spellingShingle Gulsah Gundogdu
Fatma Demirkaya Miloglu
Onur Senol
Yavuzer Koza
Fuat Gundogdu
Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS
Journal of Analytical Science and Technology
STEMI
NSTEMI
Metabolomics
LC/Q-TOF/MS/MS
title Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS
title_full Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS
title_fullStr Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS
title_full_unstemmed Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS
title_short Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS
title_sort investigation of the metabolic difference between st elevated myocardial infarction and non st elevated myocardial infarction via lc q tof ms ms
topic STEMI
NSTEMI
Metabolomics
LC/Q-TOF/MS/MS
url http://link.springer.com/article/10.1186/s40543-019-0191-3
work_keys_str_mv AT gulsahgundogdu investigationofthemetabolicdifferencebetweenstelevatedmyocardialinfarctionandnonstelevatedmyocardialinfarctionvialcqtofmsms
AT fatmademirkayamiloglu investigationofthemetabolicdifferencebetweenstelevatedmyocardialinfarctionandnonstelevatedmyocardialinfarctionvialcqtofmsms
AT onursenol investigationofthemetabolicdifferencebetweenstelevatedmyocardialinfarctionandnonstelevatedmyocardialinfarctionvialcqtofmsms
AT yavuzerkoza investigationofthemetabolicdifferencebetweenstelevatedmyocardialinfarctionandnonstelevatedmyocardialinfarctionvialcqtofmsms
AT fuatgundogdu investigationofthemetabolicdifferencebetweenstelevatedmyocardialinfarctionandnonstelevatedmyocardialinfarctionvialcqtofmsms